drugset / Trial / NCT03941626
Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies
NaSingle-groupOpen-labelTreatment
Summary
This is a single arm, open-label, uni-center, phase I-II study to evaluate the safety and effectiveness of CAR-T/TCR-T cell immunotherapy in treating with different malignancies patients.
Timeline
- Start
- 2019-09-01
- Primary completion
- 2021-05-01
- Completion
- 2021-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CAR-T/TCR-T cells | Cell therapy | — | Other |
| Background | Cyclophosphamide | Other / unclassified | — | — |
| Background | Fludarabine | Small molecule | — | — |